Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Blesa

Showing results (41-50 of 158) with videos related to

Pageof 16
Sort By:
Neurobiology of Aging|April 17, 2012
Expansion mutation in C9ORF72 does not influence plasma progranulin levels in frontotemporal dementiaOriol Dols-Icardo, Marc Suárez-Calvet, Isabel Hernández, et al.
Journal of Alzheimer'S Disease : JAD|October 22, 2016
Effect Size Analyses of Souvenaid in Patients with Alzheimer's DiseaseJeffrey Cummings, Philip Scheltens, Ian McKeith, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 25, 2018
Alzheimer's disease in Down syndrome: An overlooked population for prevention trialsAndré Strydom, Antonia Coppus, Rafael Blesa, et al.
American Journal of Alzheimer'S Disease and Other Dementias|May 23, 2013
Comparison of 2 diagnostic criteria for the behavioral variant of frontotemporal dementiaSónia Costa, Marc Suárez-Calvet, Sofia Antón, et al.
Alzheimer Disease and Associated Disorders|January 4, 2014
Reelin signaling pathway genotypes and Alzheimer disease in a Spanish populationEnric Bufill, Pere Roura-Poch, Isabel Sala-Matavera, et al.
Alzheimer Disease and Associated Disorders|November 30, 2006
Relationship between the efficacy of rivastigmine and apolipoprotein E (epsilon4) in patients with mild to moderately severe Alzheimer diseaseRafael Blesa, Miquel Aguilar, Jordi Peña Casanova, et al.
Neurology|February 14, 2014
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIgLuis Querol, Gisela Nogales-Gadea, Ricardo Rojas-Garcia, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 11, 2015
Copy number variation analysis of the 17q21.31 region and its role in neurodegenerative diseasesLaura Cervera-Carles, Javier Pagonabarraga, Berta Pascual-Sedano, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2018
Elevated YKL-40 and low sAPPβ:YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLDDaniel Alcolea, David J Irwin, Ignacio Illán-Gala, et al.
Journal of Neuropathology and Experimental Neurology|December 24, 2008
Early-onset familial lewy body dementia with extensive tauopathy: a clinical, genetic, and neuropathological studyJordi Clarimón, Laura Molina-Porcel, Teresa Gómez-Isla, et al.
Pageof 16

Showing results (41-50 of 158) with videos related to

Sort By:
Pageof 16
Neurobiology of Aging|April 17, 2012
Expansion mutation in C9ORF72 does not influence plasma progranulin levels in frontotemporal dementiaOriol Dols-Icardo, Marc Suárez-Calvet, Isabel Hernández, et al.
Journal of Alzheimer'S Disease : JAD|October 22, 2016
Effect Size Analyses of Souvenaid in Patients with Alzheimer's DiseaseJeffrey Cummings, Philip Scheltens, Ian McKeith, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 25, 2018
Alzheimer's disease in Down syndrome: An overlooked population for prevention trialsAndré Strydom, Antonia Coppus, Rafael Blesa, et al.
American Journal of Alzheimer'S Disease and Other Dementias|May 23, 2013
Comparison of 2 diagnostic criteria for the behavioral variant of frontotemporal dementiaSónia Costa, Marc Suárez-Calvet, Sofia Antón, et al.
Alzheimer Disease and Associated Disorders|January 4, 2014
Reelin signaling pathway genotypes and Alzheimer disease in a Spanish populationEnric Bufill, Pere Roura-Poch, Isabel Sala-Matavera, et al.
Alzheimer Disease and Associated Disorders|November 30, 2006
Relationship between the efficacy of rivastigmine and apolipoprotein E (epsilon4) in patients with mild to moderately severe Alzheimer diseaseRafael Blesa, Miquel Aguilar, Jordi Peña Casanova, et al.
Neurology|February 14, 2014
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIgLuis Querol, Gisela Nogales-Gadea, Ricardo Rojas-Garcia, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 11, 2015
Copy number variation analysis of the 17q21.31 region and its role in neurodegenerative diseasesLaura Cervera-Carles, Javier Pagonabarraga, Berta Pascual-Sedano, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2018
Elevated YKL-40 and low sAPPβ:YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLDDaniel Alcolea, David J Irwin, Ignacio Illán-Gala, et al.
Journal of Neuropathology and Experimental Neurology|December 24, 2008
Early-onset familial lewy body dementia with extensive tauopathy: a clinical, genetic, and neuropathological studyJordi Clarimón, Laura Molina-Porcel, Teresa Gómez-Isla, et al.
Pageof 16